Playback speed
10 seconds
ASCO 2022 Phase 2 Study of Trastuzumab Deruxtecan in the Neoadjuvant Treatment for HER2+ Gastric and GEJ Adenocarcinoma
By
ASCO 2022 Conference Coverage
FEATURING
Daisuke Takahari
By
ASCO 2022 Conference Coverage
FEATURING
Daisuke Takahari
130 views
June 17, 2022
Comments 0
Login to view comments.
Click here to Login
Recommended
AUTOPLAY